• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS TAQSCREEN MPX TEST V2; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GROUP M AND O RNA, HIV-2 RNA, HCV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS TAQSCREEN MPX TEST V2; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GROUP M AND O RNA, HIV-2 RNA, HCV Back to Search Results
Catalog Number 05969484190
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/18/2021
Event Type  malfunction  
Event Description
A customer from (b)(6) alleged the generation of discrepant results compared to the serology result when using the cobas taqscreen mpx test, v2.0, lot h02619.A donation generated a non-reactive result in pool of 6 and the serology result was hcv reactive.Resolution testing in pool of 1 generated a hbv reactive result.Repeat of of the resolution testing in pool of 1 generated a non-reactive result.No harm was alleged.An investigation is on-going.
 
Manufacturer Narrative
An investigation is on-going.A supplemental report will be filed upon completion of the investigation.Facility name was truncated due to characters limits.The complete facility name is (b)(6).(b)(4).
 
Manufacturer Narrative
An investigation of the reagent kit lot h02619 did not identify any product issue.The alleged sample were returned for investigation.The returned sample was tested in triplicate, using a quantitative hcv test (cobas® hcv, processing volume 650ul) and the sample generated a hcv target not detected result for all 3 replicates.A possible cause for the hbv and hcv reactive results at the customer site could be a laboratory contamination; however, the customer stated it was unlikely as they did not know of any potential source of contamination in their lab.An occult hbv infection cannot be excluded but as they are rare it does seem unlikely.The customer further stated that they suspected potential false positive serology results as an explanation for the non-reactive nat results.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS TAQSCREEN MPX TEST V2
Type of Device
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GROUP M AND O RNA, HIV-2 RNA, HCV
Manufacturer (Section D)
ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG
1080 us highway 202 south
branchburg NJ 08876
MDR Report Key12492448
MDR Text Key281734272
Report Number2243471-2021-03300
Device Sequence Number1
Product Code QHO
UDI-Device Identifier00875197004045
UDI-Public00875197004045
Combination Product (y/n)N
PMA/PMN Number
BL125459
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 11/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2022
Device Catalogue Number05969484190
Device Lot NumberH02619
Initial Date Manufacturer Received 08/18/2021
Initial Date FDA Received09/17/2021
Supplement Dates Manufacturer Received10/22/2021
Supplement Dates FDA Received11/02/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-